Navigating Formulary Updates: Insurance Changes and Generic Switching in 2026
Your prescription costs didn't just go up because you forgot to budget. They likely changed because your insurance plan quietly updated its formulary. If you've ever received a notice that your usual medication is now on a higher tier or completely excluded, you are not alone. In 2025 and heading into 2026, the landscape of prescription drug coverage shifted dramatically due to the Inflation Reduction Act (IRA). These changes mean insurers are pushing harder than ever toward generic drugs and biosimilars to control costs.
Understanding these formulary updates isn't just about saving money; it's about maintaining access to the care you need without unexpected financial shocks. This guide breaks down exactly how these insurance changes work, why generic switching is happening, and what steps you can take to protect your health and your wallet.
What Are Formulary Updates and Why Do They Happen?
A formulary is simply the list of medications your insurance plan agrees to cover. It’s not static. Insurance providers and Pharmacy Benefit Managers (PBMs) update these lists annually, usually effective January 1st. The goal for them is cost containment. For you, the patient, the goal is stability. When these goals clash, you get formulary changes.
Since the introduction of Medicare Part D in 2006, formulary management has been a balancing act. However, the Inflation Reduction Act of 2022 fundamentally changed the rules of the game. Insurers are no longer incentivized by rebates from brand-name drug manufacturers. Instead, they are motivated to steer patients toward lower-cost alternatives like generics and biosimilars. This shift explains the aggressive generic substitution policies we are seeing in 2025 and 2026.
Who decides which drugs are on my formulary?
Pharmacy Benefit Managers (PBMs) and insurance companies decide formulary coverage based on clinical effectiveness, safety, and cost. Major PBMs like OptumRx, CVS Caremark, and Express Scripts dominate this space, influencing which drugs are preferred or excluded across millions of plans.
The Four Ways Your Coverage Can Change
When your insurer sends a notice about formulary changes, it usually falls into one of four categories. Knowing which bucket your drug lands in determines how much effort you’ll need to put in to keep taking it.
- Complete Exclusion: The drug is removed from the plan entirely. You will have to pay full price unless you successfully appeal or switch doctors' prescriptions.
- Tier Reassignment: The drug stays covered but moves to a higher cost-sharing tier. For example, moving from Tier 1 (preferred generic) to Tier 3 (non-preferred brand) can increase your copay from $5 to over $100.
- Prior Authorization (PA): Your doctor must prove to the insurer that you specifically need this drug before they will cover it. This adds administrative time but doesn't necessarily change the cost if approved.
- Step Therapy: You must try and fail on a cheaper alternative (usually a generic) before the insurer will cover the more expensive drug your doctor originally prescribed.
In 2025, data showed that standalone Prescription Drug Plans (PDPs) were far more aggressive with these changes than Medicare Advantage plans. About 78% of PDP formularies implemented substantial generic substitution policies, compared to only 42% in the Medicare Advantage market. If you are in a PDP, expect stricter scrutiny on your prescriptions.
Generic Switching and the Rise of Biosimilars
The biggest driver of current formulary updates is the push for generic switching. But it’s not just about old-school generic pills anymore. It’s also about biosimilars-biologic drugs that are highly similar to reference biologics already approved by the FDA.
Insurers love biosimilars because they break the monopoly of expensive brand-name biologics. For instance, if you were taking Humira for arthritis or Crohn's disease, your insurer might have switched you to Amjevita, a biosimilar. Many patients report no difference in effectiveness, but significant savings. One user shared that switching saved them $450 monthly.
However, not all switches are seamless. The FDA updated its guidance on biosimilar interchangeability in May 2024, giving PBMs more confidence to cover biosimilars even without the specific "interchangeable" designation. While this helps lower costs, it can cause anxiety for patients who feel their specific treatment was working perfectly. Always discuss biosimilar switches with your doctor to ensure there are no clinical reasons to stay on the original brand.
Cost Savings: The ,000 Out-of-Pocket Cap
Amidst the confusion of formulary changes, there is a major silver lining for many patients: the new out-of-pocket cap. Starting January 1, 2025, the Inflation Reduction Act capped annual out-of-pocket prescription drug expenses at $2,000 for Medicare Part D enrollees.
This eliminates the infamous "donut hole" or coverage gap. Once you spend $2,000 in a year, the plan covers 100% of your drug costs. According to AARP analysis, an estimated 3.2 million beneficiaries will save an average of $1,500 in 2025 thanks to this cap. Some high-need patients are saving $3,000 or more. This cap provides a crucial safety net, ensuring that even if your copays rise due to tier reassignments, your total annual spending won't spiral out of control.
| Formulary Tier | Drug Type | Average Copay (2025) |
|---|---|---|
| Tier 1 | Preferred Generics | $1 - $10 |
| Tier 2 | Non-Preferred Generics / Preferred Brands | $47 |
| Tier 3 | Non-Preferred Brands | $113 |
| Specialty | High-Cost Medications | $113 or 25% Coinsurance |
How to Navigate Changes: A Step-by-Step Guide
You don't have to accept a formulary change passively. Here is how to fight back if your medication is affected.
1. Review Your Notice Early
CMS mandates that insurers provide 60-day advance notice for formulary changes affecting existing medications. Check your mail between October and December each year. If you see a change, act immediately. Don't wait until January 1st when the change takes effect.
2. Talk to Your Pharmacist
Your pharmacist is your best ally. Ask them if there is a therapeutic equivalent on a lower tier. Sometimes, a slight change in dosage form or manufacturer can drop you back to Tier 1. Pharmacists often know which exceptions are easiest to approve.
3. File an Exception Request
If no alternative works, you can file a formulary exception. There are two types:
- Standard Exception: Processed within 72 hours. Good for non-urgent issues.
- Expedited Exception: Processed within 24 hours. Use this if stopping your medication would seriously harm your health.
4. Consider Plan Changes During Open Enrollment
If your current plan consistently excludes your necessary medications, consider switching during the Annual Election Period (October 15 - December 7). Compare plans using the Medicare Plan Finder tool to see which ones keep your drugs on lower tiers.
Looking Ahead: What to Expect in 2026
The changes aren't stopping. In 2026, the Medicare Drug Price Negotiation Program (MDPNP) kicks into high gear. This program requires all Part D formularies to cover specific negotiated drugs, including Stelara (for psoriasis), Prolia (for osteoporosis), and Xolair (for asthma/allergies).
While this sounds like good news for access, it may lead to further restrictions elsewhere as plans balance their budgets. Analysts project that 65% of 2026 formularies will implement mandatory generic substitution policies for all non-protected classes where biosimilars exist. Additionally, biosimilar adoption is accelerating, with 17 new biosimilars approved in 2024 alone. Expect more switches from brands like Enbrel and Remicade to their biosimilar counterparts in the coming year.
Frequently Asked Questions
Can my insurance force me to switch to a generic?
Yes, if your plan includes automatic generic substitution clauses. Most plans do. However, you can request an exception if your doctor certifies that the generic is medically ineffective for you. This is rare for simple generics but more common with complex biologics.
What is a transitional supply?
If your drug is suddenly excluded, most plans offer a 30-day transitional supply. This gives you enough time to talk to your doctor and find an alternative without missing a dose. Call your pharmacy immediately upon receiving the exclusion notice to request this.
Are biosimilars as safe as brand-name biologics?
Yes. The FDA requires biosimilars to be highly similar to the reference product with no clinically meaningful differences in safety, purity, or potency. They undergo rigorous testing. However, individual responses can vary, so monitoring with your doctor is essential after a switch.
Why did my copay jump from $35 to $113 overnight?
This is likely a tier reassignment. Your drug moved from a preferred tier to a non-preferred tier. This often happens when a generic version becomes available, or the insurer loses a rebate deal with the manufacturer. Check your Summary of Benefits to see the new tier placement.
Will the $2,000 cap apply to every drug I take?
The cap applies to your total out-of-pocket spending on covered Part D drugs. Once you hit $2,000, the plan pays 100%. Note that this cap does not include the cost of the premiums you pay monthly, only the copays and coinsurance for the medications themselves.